Vericrest Private Wealth’s Precision BioSciences DTIL Stock Holding History

Vericrest Private Wealth’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$248K	Buy	+5,156	New	+$303K	0.3%	35

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vericrest Private Wealth's DTIL Position: Q2 2022 in Review

Vericrest Private Wealth opened a new position in Precision BioSciences (DTIL) in Q2 2022: 5,156 shares worth $248K. The stake represents 0.3% of the portfolio and ranks #35 among its holdings.

119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

Vericrest Private Wealth held 5,156 shares of Precision BioSciences worth $248K as of Q2 2022.
Precision BioSciences was a new Vericrest Private Wealth position in Q2 2022.
Precision BioSciences made up 0.3% of Vericrest Private Wealth's portfolio in Q2 2022, its #35 holding.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Vericrest Private Wealth's 13F filing for Q2 2022, filed 15 Aug 2022.